Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT PHARMOVA    ACTAVIS
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-23
ACTAVIS
Dec-18
JUBILANT PHARMOVA /
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs49616,159-   
Low Rs26910,840-   
Sales per share (Unadj.) Rs394.43,963.8-  
Earnings per share (Unadj.) Rs-4.1-1,276.8-  
Cash flow per share (Unadj.) Rs30.7417.7-  
Dividends per share (Unadj.) Rs5.000-  
Avg Dividend yield %1.30-  
Book value per share (Unadj.) Rs338.616,349.0-  
Shares outstanding (eoy) m159.28332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.03.4 28.5%   
Avg P/E ratio x-93.8-10.6 887.4%  
P/CF ratio (eoy) x12.432.3 38.5%  
Price / Book Value ratio x1.10.8 136.7%  
Dividend payout %-122.70-   
Avg Mkt Cap Rs m60,8734,489,898 1.4%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m21,6600-   
Avg. sales/employee Rs Th078,010.2-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,127.1-  
INCOME DATA
Net Sales Rs m62,8171,318,372 4.8%  
Other income Rs m38325,212 1.5%   
Total revenues Rs m63,2011,343,584 4.7%   
Gross profit Rs m7,31734,548 21.2%  
Depreciation Rs m5,540563,576 1.0%   
Interest Rs m1,88276,078 2.5%   
Profit before tax Rs m278-579,893 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,896 0.0%   
Tax Rs m927-7,349 -12.6%   
Profit after tax Rs m-649-424,648 0.2%  
Gross profit margin %11.62.6 444.5%  
Effective tax rate %333.51.3 26,319.7%   
Net profit margin %-1.0-32.2 3.2%  
BALANCE SHEET DATA
Current assets Rs m37,624540,727 7.0%   
Current liabilities Rs m17,724478,345 3.7%   
Net working cap to sales %31.74.7 669.5%  
Current ratio x2.11.1 187.8%  
Inventory Days Days2520 125.2%  
Debtors Days Days5666 84.2%  
Net fixed assets Rs m71,668149,232 48.0%   
Share capital Rs m1590-   
"Free" reserves Rs m53,7720-   
Net worth Rs m53,9315,437,670 1.0%   
Long term debt Rs m31,1041,914,801 1.6%   
Total assets Rs m109,2928,500,316 1.3%  
Interest coverage x1.1-6.6 -17.3%   
Debt to equity ratio x0.60.4 163.8%  
Sales to assets ratio x0.60.2 370.6%   
Return on assets %1.1-4.1 -27.5%  
Return on equity %-1.2-7.8 15.4%  
Return on capital %2.5-4.8 -52.5%  
Exports to sales %00-   
Imports to sales %4.10-   
Net fx Rs m4,5360-   
CASH FLOW
From Operations Rs m6,607471,005 1.4%  
From Investments Rs m-5,444258,756 -2.1%  
From Financial Activity Rs m-1,567-808,385 0.2%  
Net Cashflow Rs m301-78,232 -0.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare JUBILANT PHARMOVA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare JUBILANT PHARMOVA With: IOL CHEMICALS & PHARM.  WANBURY  LINK PHARMA  SMS LIFESCIENCES INDIA  ZIM LABORATORIES  



Today's Market

Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results(Closing)

It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.